Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome b5 type A (CYB5A) is a human membrane-bound hemoprotein found primarily in the endoplasmic reticulum and outer mitochondrial membrane[1][3][4][5]. Its principal role is serving as an electron carrier for enzymes involved in fatty acid desaturation, steroid biosynthesis, and xenobiotic metabolism, including cytochrome P450s. CYB5A maintains hemoglobin in its reduced, oxygen-binding form and is essential for cellular redox balance. Defects in CYB5A cause hereditary methemoglobinemia, a disorder characterized by impaired oxygen transport in blood, and impact adrenal steroidogenesis. In cancer, CYB5A expression can modulate autophagy and inhibit metastasis by interacting with key signaling pathways[6].
Metal ions (chromium-containing drugs): interact as substrates with cytochrome b5, affecting redox processes related to oxygenases and detoxification pathways; Indirect regulation: influencing electron flux to enzymes such as cytochrome P450s, affecting metabolic conversion of endogenous compounds and xenobiotics; In cancer: modulation of autophagy through inhibition of the JAK1/STAT3 pathway
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome b5 type A (CYB5A).